Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
July 21, 2021
Conducting a transparent, targeted and robust benefit-risk assessment of a new drug or product is one of the most...
Read article
March 2, 2021
Hybrid Bayesian and Frequentist Clinical Trial Designs
Most people know that clinical drug discovery is usually conducted using either Frequentist or Bayesian methods. These...
Read article
May 5, 2020
Webinar: A Clinician’s Perspective on Cancer Drugs Development
Cytel's team of oncology trial design and advanced analytics experts are hosting a series of complimentary webinars...
Read article
April 23, 2020
A Clinician’s Perspective on Cancer Drugs Development
Cytel is hosting a webinar, “A Clinician’s Perspective on Cancer Drugs Development”, on April 28, 2020. Our speaker,...
Read article
May 30, 2017
Interview: How can a Bayesian framework support benefit risk assessment?
A recent paper The case for Bayesian methods in benefit-risk assessment: Overview and future directions (1) co-authored...
Read article